Audrey Kunin serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Audrey Kunin has executed 10 insider transactions totaling $307.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 6, 2022 involved selling 1 shares valued at $2.
Audrey Kunin currently holds 1 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Audrey Kunin has been a net buyer of NBY stock. They have purchased $235.7K and sold $71.7K worth of shares.
Audrey Kunin's most recent insider trade was on Dec 6, 2022, when they sold 1 shares at $1.81 per share.
Get notified when new Form 4 filings are submitted
| $2.10 |
| Discretionary |
| Nov 21, 2022 | NBY | $12.5K | Sale | 5,960 | $2.10 | Discretionary |
| Sep 14, 2022 | NBY | $46.6K | Sale | 291,368 | $0.16 | Discretionary |
| Dec 3, 2021 | NBY | $46.8K | Purchase | 101,650 | $0.46 | Discretionary |
| Dec 2, 2021 | NBY | $125.9K | Purchase | 262,369 | $0.48 | Discretionary |
| Dec 1, 2021 | NBY | $7.3K | Purchase | 14,848 | $0.49 | Discretionary |
| Nov 30, 2021 | NBY | $13.8K | Purchase | 30,000 | $0.46 | Discretionary |
| Nov 23, 2021 | NBY | $30.4K | Purchase | 66,133 | $0.46 | Discretionary |
| Nov 22, 2021 | NBY | $11.5K | Purchase | 25,000 | $0.46 | Discretionary |